Induction of Potent Antitumor CTL Responses by Recombinant Vaccinia Encoding a Melan-A Peptide Analogue-Reference-Cited by-同舟云学术

Induction of Potent Antitumor CTL Responses by Recombinant Vaccinia Encoding a Melan-A Peptide Analogue

Published:2000-01-15 Issue:2 Volume:164 Page:1125-1131
ISSN:0022-1767
Container-title:The Journal of Immunology
language:en
Short-container-title:J Immunol

Author:

Valmori Danila,Lévy Frederic,Miconnet Isabelle,Zajac Paul,Spagnoli Giulio C.,Rimoldi Donata,Liénard Danielle,Cerundolo Vincenzo,Cerottini Jean-Charles,Romero Pedro

Publisher

The American Association of Immunologists

Subject

Immunology,Immunology and Allergy

Reference44 articles.

1. Cytolytic T lymphocyte responses of cancer patients to tumor-associated antigens

2. Human tumor antigens recognized by T cells

3. Cancer vaccines based on the identification of genes encoding cancer regression antigens

4. Serum proteases alter the antigenicity of peptides presented by class I major histocompatibility complex molecules.

Cited by 70 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The human immune checkpoint molecule, HLA-G2, induces tolerance in monocytes and dendritic cells via upregulation of PD-L1;2023-10-18

2. Replicating viral vector platform exploits alarmin signals for potent CD8+ T cell-mediated tumour immunotherapy;Nature Communications;2017-05-26

3. Xenogene vaccination in the therapy of cancer;Expert Opinion on Biological Therapy;2014-07-15

4. Plasticity in the Contribution of T Cell Receptor Variable Region Residues to Binding of Peptide–HLA-A2 Complexes;Journal of Molecular Biology;2013-11

5. A Full GMP Process to Select and Amplify Epitope-Specific T Lymphocytes for Adoptive Immunotherapy of Metastatic Melanoma;Clinical and Developmental Immunology;2013